Never miss the latest ESG news, interviews & insights. Subscribe for our weekly newsletter!
Top Banner

Lupin Debuts on TIME and Statista's World's Most Sustainable Companies 2026 List

csr

Representational image

Mumbai, July 07, 2026: Global pharma major Lupin Limited has made its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, marking recognition of the company's progress in environmental stewardship, responsible business practices, governance and social impact.

The company has been ranked 318th among the 750 firms selected from more than 5,000 of the world's largest and most influential organisations. The assessment evaluated companies across over 20 sustainability indicators, covering sustainability commitments and ratings, reporting transparency, and environmental and social performance. Lupin is among 16 Indian companies featured in this year's global ranking.

Commenting on the recognition, Ramesh Swaminathan, Executive Director, Global CFO, Head of IT and API Plus SBU, Lupin, said, "Our inclusion in TIME and Statista's World's Most Sustainable Companies 2026 marks an important recognition for us. Sustainability is central to how we drive performance while advancing our purpose. We remain committed to accelerating our climate transition, strengthening governance and transparency, scaling renewable energy, and integrating ESG enterprise-wide."

Advertisement

The recognition reflects Lupin's continued efforts to integrate Environmental, Social and Governance (ESG) priorities across its global operations, with a focus on creating long-term value for patients, communities and other stakeholders. It also builds on the company's strong ESG track record, which includes the highest 'A' leadership rating from CDP for both Climate Change and Water Security, and a score of 91 in the S&P Global Corporate Sustainability Assessment.

The listing further underlines Lupin's ongoing efforts to embed sustainability across its business operations while contributing to broader climate and social goals within the pharmaceutical sector.

Top Banner
Subscribe to our Weekly Newsletter